Johnson & Johnson COVID-19 booster shot bolsters immune defense, FDA staff say
Fox News
A booster of Johnson & Johnson’s Covid-19 vaccine showed signs of significantly bolstering the immune defenses of study subjects, federal health regulators said Wednesday.
The Food and Drug Administration staff gave their assessment of the J&J booster data as part of the agency’s review of the company’s request for authorization of the second dose.
After authorizing boosters for seniors and certain high-risk people who got the COVID-19 vaccine from Pfizer Inc. and BioNTech SE, the FDA is now considering whether to clear extra doses of the shots from J&J and Moderna. It is also weighing whether doses could be mixed among different vaccines.
More Related News